Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.
about
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugsIncidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year periodIntimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CARisk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention.Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youthHepatitis C virus risk behaviors within the partnerships of young injecting drug users.Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaThe impact of methadone maintenance therapy on hepatitis C incidence among illicit drug usersAssociations between prescription opioid injection and Hepatitis C virus among young injection drug users.The growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction.Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.Initiation into prescription opioid misuse amongst young injection drug usersThe undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trialOpioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.Cost-effectiveness and population outcomes of general population screening for hepatitis C.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisMore than just someone to inject drugs with: Injecting within primary injection partnerships.Patterns of prescription drug misuse among young injection drug users.Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.Epidemiology of Injection Drug Use: New Trends and Prominent Issues.Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive preventionHepatitis C virus vaccines among people who inject drugs.Global control of hepatitis C: where challenge meets opportunityBarriers to practicing risk reduction strategies among people who inject drugs.Can intranasal drug use reduce HCV infection among injecting drug users?Transitions from injecting to non-injecting drug use: potential protection against HCV infection.Evolving epidemiology of hepatitis C virus in the United States.Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.Utilization of buprenorphine and methadone among opioid users who inject drugs.Staying safe from hepatitis C: engaging with multiple priorities.Substance abuse treatment utilization, HIV risk behaviors, and recruitment among suburban injection drug users in Long Island, New York.Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut
P2860
Q24629455-A469A6DB-87DD-459B-8F65-2FF2558B1F9EQ28540278-F7995566-BA4C-4391-9239-4EDE0602CD88Q28543558-AD6F54B6-3DB2-447B-8702-51B9C1D04936Q30713067-428DC30D-52B9-410A-AFA4-3A749C0F7331Q33711886-C2B44E7D-9FAE-4C00-A2B7-999F34C86998Q33809640-FC1A612C-787C-420B-ABD2-23ACFD86614FQ33996279-40FB8005-8137-4F8A-8F9F-D0FEB42A465CQ34009271-690E5832-BFC7-4730-AF75-AA8A26CE47EBQ34415820-CD0CA0F4-3638-457E-8946-2E0C083DEA75Q34498633-183C5878-DFA2-42A8-B8DE-B6BC4CCED4C5Q34971493-BD35CA52-D6D9-44FC-99B6-1EB91B4CF9A2Q35179636-481A1F75-E91A-40CC-85FC-BFF7BC45DA21Q35235877-CF2A4364-FBFD-4F96-B30A-75F655D20F38Q35388380-5A93050A-38B1-4604-B4C7-880FF5CF3B4BQ35593482-45935A75-2076-48D8-930E-6BCBD09381C1Q35947066-2CD32119-5CF5-4644-A3EC-622E1E6538FEQ35981551-13E377D3-4E01-4BBC-A836-AF6CC76353DBQ36093144-05F4DFFC-5D65-4CA9-B5C5-75A607F82A98Q36115516-1D1637CB-04BA-4E07-AF70-9AA127632260Q36123263-C75EEA87-B99C-456B-A932-0B14C5866817Q36248999-2517DD44-0FFA-48D5-818D-4814C9BCCB25Q36491880-689C3085-4517-4923-8CC7-8C7BE5B3381AQ36727287-85A0FA36-37CF-474A-A00C-28EBD1622E1BQ36744335-F43648D5-8B24-4E9D-B478-7C1E43CF1F5DQ36882030-FA512490-7AAF-426F-82C1-9E12045562FAQ36882069-99D30129-B5D2-4350-838E-19D03C99591EQ36922133-9E4FF674-1D53-4A71-8924-69C71BABAEABQ37015619-1535E922-D6DE-4CA3-AD93-A8090C666538Q37042431-73158714-9391-4AB6-B2A0-3208FE547E41Q37042440-92090516-16B9-4712-A5BB-559E416C6951Q37077112-772A8AFE-EA3E-4B25-BF46-5DC6C24825F3Q37149214-0290D31F-ECA6-4B41-BA9C-3A63E1666211Q37505027-1BB9F3A6-8390-4FEB-BD82-F20E3395F3F7Q37625564-C916CBD6-1741-46D7-9945-37051ED1AEFCQ38020157-DF52DEF8-FAC2-4105-AA03-BAC3D158D8F8Q38627006-EAE89CE8-D974-45A4-A778-A6D3E8071C90Q38630550-BF52DD4A-D73C-4B2E-B101-161755A09766Q39050468-70F175A4-2AD0-4227-865C-036941850F88Q39412392-09D3A846-20D5-47FF-B2F3-39B090314748Q39855070-95F317C9-650B-491F-967E-6CAE8862E5A7
P2860
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@en
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@nl
type
label
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@en
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@nl
prefLabel
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@en
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@nl
P2093
P356
P1476
Attribution of hepatitis C vir ...... ion drug users in 5 US cities.
@en
P2093
Enrique R Pouget
Holly Hagan
Ian T Williams
Lawrence J Ouellet
Mary H Latka
Richard L Garfein
Sharon M Hudson
P304
P356
10.1086/649783
P407
P577
2010-02-01T00:00:00Z